Correlation Between Sk Biopharmaceutica and ABL Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sk Biopharmaceutica and ABL Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sk Biopharmaceutica and ABL Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sk Biopharmaceuticals Co and ABL Bio, you can compare the effects of market volatilities on Sk Biopharmaceutica and ABL Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sk Biopharmaceutica with a short position of ABL Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sk Biopharmaceutica and ABL Bio.

Diversification Opportunities for Sk Biopharmaceutica and ABL Bio

0.9
  Correlation Coefficient

Almost no diversification

The 3 months correlation between 326030 and ABL is 0.9. Overlapping area represents the amount of risk that can be diversified away by holding Sk Biopharmaceuticals Co and ABL Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ABL Bio and Sk Biopharmaceutica is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sk Biopharmaceuticals Co are associated (or correlated) with ABL Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ABL Bio has no effect on the direction of Sk Biopharmaceutica i.e., Sk Biopharmaceutica and ABL Bio go up and down completely randomly.

Pair Corralation between Sk Biopharmaceutica and ABL Bio

Assuming the 90 days trading horizon Sk Biopharmaceuticals Co is expected to generate 0.63 times more return on investment than ABL Bio. However, Sk Biopharmaceuticals Co is 1.59 times less risky than ABL Bio. It trades about -0.29 of its potential returns per unit of risk. ABL Bio is currently generating about -0.28 per unit of risk. If you would invest  11,970,000  in Sk Biopharmaceuticals Co on August 28, 2024 and sell it today you would lose (2,200,000) from holding Sk Biopharmaceuticals Co or give up 18.38% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Strong
Accuracy100.0%
ValuesDaily Returns

Sk Biopharmaceuticals Co  vs.  ABL Bio

 Performance 
       Timeline  
Sk Biopharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sk Biopharmaceuticals Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
ABL Bio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ABL Bio has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Sk Biopharmaceutica and ABL Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sk Biopharmaceutica and ABL Bio

The main advantage of trading using opposite Sk Biopharmaceutica and ABL Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sk Biopharmaceutica position performs unexpectedly, ABL Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ABL Bio will offset losses from the drop in ABL Bio's long position.
The idea behind Sk Biopharmaceuticals Co and ABL Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Other Complementary Tools

Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Equity Valuation
Check real value of public entities based on technical and fundamental data
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges